Company / SG&A Expense
Cosmos Health Inc. SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$15.6M
FY2025
5-year range
$9.2M / $19.6M
FY2021-FY2025
Trend
+33.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A Expense has fluctuated over the past 10 years, ranging from $486,036 in FY2016 to $20M in FY2023.
Based on SEC 10-K filings.
$16M in FY2025 with a 5-year CAGR of +49.3%.
Improved from $20M to $16M over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +15.3%
- 5-Year CAGR
- +49.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +49.3%, indicating consistent growth.
- In FY2025, sg&a expense increased 33.1% year-over-year.
- Peak sg&a expense was recorded in FY2023.
- Lowest sg&a expense in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -1.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $15.6M | +33.1% |
| FY2024 | $11.7M | -40.3% |
| FY2023 | $19.6M | +92.9% |
| FY2022 | $10.2M | +10.6% |
| FY2021 | $9.2M | +337.9% |
| FY2020 | $2.1M | -36.1% |
| FY2019 | $3.3M | -8.5% |
| FY2018 | $3.6M | +352.5% |
| FY2017 | $794.1K | +63.4% |
| FY2016 | $486.0K | +0.0% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026